Hypertension Pharmacogenomic Test
Treatment guidance for hypertension
Key Facts
About Geneticure
Geneticure operates in the precision medicine diagnostics sector, focusing on the massive and underserved global hypertension market. The company's proprietary multi-gene algorithm analyzes patient DNA to predict response to various blood pressure medications, aiming to replace the standard trial-and-error approach with a genetically-guided first-line therapy. Backed by research published in peer-reviewed journals and notable investors like the Mayo Clinic, Geneticure's commercial test is designed to improve patient outcomes, reduce cardiovascular events, and lower overall healthcare costs. The company is privately held and appears to be in an early revenue stage, commercializing its diagnostic directly to patients and clinicians.
View full company profile